RECURSION PHARMACEUTICALS, INC.（RXRX）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 RECURSION PHARMACEUTICALS, INC.（RXRX）报告了 142 笔 Form 4 交易（最近一笔 2026-10-07）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-07 | HERSHBERG ROBERT | 董事 | 买入 | 25,000 | $55,500 |
| 2026-10-07 | Borgeson Blake | 董事 | 卖出 | 50,000 | $242,000 |
| 2026-10-07 | HERSHBERG ROBERT | 董事 | 卖出 | 25,000 | $125,000 |
| 2026-10-02 | Li Dean Y | 董事 | 买入 | 3,378 | $0 |
| 2026-10-02 | Dar Zavain | 董事 | 买入 | 4,607 | $0 |
| 2026-09-16 | Taylor Ben R | Chief Financial Officer | 卖出 | 5,396 | $18,400 |
| 2026-09-10 | Khan Najat | CEO and President | 卖出 | 22,408 | $78,822 |
| 2026-09-02 | Borgeson Blake | 董事 | 卖出 | 30,000 | $100,200 |
| 2026-08-18 | Taylor Ben R | Chief Financial Officer | 卖出 | 25,018 | $79,057 |
| 2026-08-18 | Hallett David | Chief Scientific Officer | 卖出 | 26,657 | $84,236 |
| 2026-08-18 | Khan Najat | CEO and President | 卖出 | 80,498 | $254,374 |
| 2026-08-06 | Borgeson Blake | 董事 | 卖出 | 30,000 | $97,500 |
| 2026-07-09 | Borgeson Blake | 董事 | 卖出 | 40,000 | $158,500 |
| 2026-07-02 | Li Dean Y | 董事 | 买入 | 3,747 | $0 |
| 2026-07-02 | Dar Zavain | 董事 | 买入 | 5,109 | $0 |
| 2026-06-22 | HERSHBERG ROBERT | 董事 | 买入 | 88,424 | $0 |
| 2026-06-22 | Borgeson Blake | 董事 | 买入 | 88,424 | $0 |
| 2026-06-22 | Dar Zavain | 董事 | 买入 | 88,424 | $0 |
| 2026-06-22 | Li Dean Y | 董事 | 买入 | 88,424 | $0 |
| 2026-06-22 | Michor Franziska | 董事 | 买入 | 88,424 | $0 |
| 2026-06-22 | Bumpus Namandje | 董事 | 买入 | 88,424 | $0 |
| 2026-06-22 | Bumpus Namandje | 董事 | 卖出 | 3,963 | $12,602 |
| 2026-06-22 | Sun Elaine D | 董事 | 买入 | 88,424 | $0 |
| 2026-06-17 | Taylor Ben R | Chief Financial Officer | 卖出 | 5,396 | $16,997 |
| 2026-06-05 | Gibson Christopher | 董事 | 买入 | 40,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-07